Flamel Technologies, Inc

Latest News

March 8, 2010
Flamel Technologies Announces Fourth Quarter and Year-End 2009 Results

A conference call to discuss the earnings is scheduled for 8:30 AM EST on March 09, 2010.
The dial-in number (for investors in the U.S. and Canada) is 1-877-857-6173; the conference ID number is 2453008.
International investors are invited to dial 1 719-325-4888.
Webcast

March 1, 2010
Flamel Technologies Announces Projected Release Date of Fourth Quarter and Annual Results; Conference Call

December 18, 2009
Flamel Technologies Announces the Initiation of a Phase 2a Clinical Trial of Flamel's IFN-Alpha-2b XL in Patients with Chronic Hepatitis C Virus Infection

November 16, 2009
Flamel Technologies Announces Third Quarter 2009 Results; Additional New Projects; Cash Increases from $45.1 to $48.8 million
A conference call to discuss earnings is scheduled for 8:30 AM EST November 16, 2009.
The dial-in number (for investors in the U.S. and Canada) is 1-800-860-2442; the conference ID number is 435349.
International investors are invited to dial 1 412-858-4600.
Webcast

November 04, 2009
Flamel Technologies Announces Licensing Agreement with Pfizer

September 18, 2009
Flamel Technologies to Present at UBS Global Life Sciences Conference

Medusa®

A Versatile Nano Carrier for the Delivery of Native Proteins

Medusa®, a self-assembled poly-aminoacid nanoparticles system, is a versatile protein carrier for the development of novel and second-generation long-acting native protein drugs. more info

Micropump® Technologies

From Pediatric to Geriatric Uses

Controlled-release systems permitting either extended (Micropump® I) or both delayed and extended (Micropump® II) delivery of small molecule drugs.

more info

For more information about Flamel's drug delivery technologies, product development capabilities, and business partnerships, please contact:

In Europe

Stephen H. Willard
Chief Executive Officer
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435
E-mail: willard@flamel.com

Rafael Jorda, Ph.D.
Vice President, Director of Manufacturing and Development
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435
E-mail: jorda@flamel.com

Jeffery S. Vick
Chief Business Officer
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435
E-mail: vick@flamel.com

In the USA

Nigel McWilliam,
Director, Business Development, USA
E-mail: mcwilliam@flamel.com

Office Locations

Headquarters
33 avenue du Dr. Georges Levy
69693 Venissieux Cedex
France
Phone: +33 (0) 472 783 434
Fax: +33 (0) 472 783 435

Manufacturing Facility
11 avenue Gustave Eiffel
33608 Pessac Cedex
France
Phone: +33 (0) 557 260 770
Fax: +33 (0) 556 365 891